LadRx Corp
DelistedCIK 799698fmd_11CR9W0S2ZPRGP73BJHD8Z0KBGManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2009 to Mar 31, 2025, 61 periods
Latest annual · FY2024
Millions- Operating income
- (4)
- Net income
- (2)
Latest quarter · Q1 FY2025
Millions- Operating income
- (1)
- Net income
- (1)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2019 to FY2024
- n/m
LadRx Corp financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Operating income | -$3.6 million | -$3.8 million | 10-K 2025-03-28 · proof | |
| Net income | -$1.6 million | $400,443 | -497% | 10-K 2025-03-28 · proof |
| Cash from operating activities | -$1.3 million | $1 million | -229.2% | 10-K 2025-03-28 · proof |
| Total assets | $839,512 | $2.3 million | -63.6% | 10-K 2025-03-28 · proof |
| Total liabilities | $2.3 million | $2.2 million | +2.7% | 10-K 2025-03-28 · proof |
| Cash and cash equivalents | $759,742 | $2.1 million | -63.3% | 10-K 2025-03-28 · proof |
- What was LadRx Corp's operating income in fiscal 2024?
- LadRx Corp reported operating income of -$3.6 million for fiscal 2024 (the year ended Dec 31, 2024), against -$3.8 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2025. SEC
- What was LadRx Corp's net income in fiscal 2024?
- LadRx Corp reported net income of -$1.6 million for fiscal 2024 (the year ended Dec 31, 2024), against $400,443 the year before (-497%). Source: the 10-K filed with the SEC on Mar 28, 2025. SEC
- What was LadRx Corp's cash from operating activities in fiscal 2024?
- LadRx Corp reported cash from operating activities of -$1.3 million for fiscal 2024 (the year ended Dec 31, 2024), against $1 million the year before (-229.2%). Source: the 10-K filed with the SEC on Mar 28, 2025. SEC
- What are LadRx Corp's total assets?
- As of Dec 31, 2024, LadRx Corp reported total assets of $839,512, against $2.3 million a year earlier (-63.6%). Source: the 10-K filed with the SEC on Mar 28, 2025. SEC
- What are LadRx Corp's total liabilities?
- As of Dec 31, 2024, LadRx Corp reported total liabilities of $2.3 million, against $2.2 million a year earlier (+2.7%). Source: the 10-K filed with the SEC on Mar 28, 2025. SEC
- What are LadRx Corp's cash and cash equivalents?
- As of Dec 31, 2024, LadRx Corp reported cash and cash equivalents of $759,742, against $2.1 million a year earlier (-63.3%). Source: the 10-K filed with the SEC on Mar 28, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:799698&period_type=annual&limit=5"Information only, not investment advice.